Related references
Note: Only part of the references are listed.Everolimus and Early Calcineurin Inhibitor Withdrawal: 3-Year Results From a Randomized Trial in Liver Transplantation
M. Sterneck et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review
Evangelos Cholongitas et al.
TRANSPLANT INTERNATIONAL (2014)
The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence
Goran B. Klintmalm et al.
JOURNAL OF TRANSPLANTATION (2014)
Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study
F. Saliba et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Everolimus Monotherapy or Combined Therapy in Liver Transplantation: Indications and Results
C. Alegre et al.
TRANSPLANTATION PROCEEDINGS (2013)
A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation - PROTECT
L. Fischer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
P. De Simone et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation
Robert M. Langer et al.
TRANSPLANT INTERNATIONAL (2012)
Antitumor Efficacy of Mammalian Target of Rapamycin Inhibitor Therapy in Liver Transplant Recipients With Oncological Disease: A Case-Control Study
J. M. Alamo et al.
TRANSPLANTATION PROCEEDINGS (2012)
Limiting Hepatitis C Virus Progression in Liver Transplant Recipients Using Sirolimus-Based Immunosuppression
G. J. McKenna et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
m-TOR inhibitors: What role in liver transplantation?
Toshiyasu Kawahara et al.
JOURNAL OF HEPATOLOGY (2011)
Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis
Eleonora Patsenker et al.
JOURNAL OF HEPATOLOGY (2011)
Conversion to Everolimus in Maintenance Liver Transplant Patients: A Multicenter, Retrospective Analysis
Faouzi Saliba et al.
LIVER TRANSPLANTATION (2011)
Early Withdrawal of Calcineurin Inhibitors and Everolimus Monotherapy in de novo Liver Transplant Recipients Preserves Renal Function
M. Masetti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Everolimus Plus Reduced-Exposure CsA versus Mycophenolic Acid Plus Standard-Exposure CsA in Renal-Transplant Recipients
H. Tedesco Silva et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Sirolimus-Based Immunosuppression Is Associated with Increased Survival After Liver Transplantation for Hepatocellular Carcinoma
Christian Toso et al.
HEPATOLOGY (2010)
Management of Hepatocellular Carcinoma Recurrence After Liver Transplantation
A. Valdivieso et al.
TRANSPLANTATION PROCEEDINGS (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Outcomes After Liver Transplantation: Chronic Kidney Disease
Ranjeeta Bahirwani et al.
LIVER TRANSPLANTATION (2009)
Improvement of Renal Function After the Switch from a Calcineurin Inhibitor to Everolimus in Liver Transplant Recipients with Chronic Renal Dysfunction
Javier F. Castroagudin et al.
LIVER TRANSPLANTATION (2009)
Conversion from a Calcineurin Inhibitor to Everolimus Therapy in Maintenance Liver Transplant Recipients: A Prospective, Randomized, Multicenter Trial
Paolo De Simone et al.
LIVER TRANSPLANTATION (2009)
Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function
Paolo De Simone et al.
TRANSPLANT INTERNATIONAL (2009)
Efficacy, Tolerance, and Safety of Mammalian Target of Rapamycin Inhibitors as Rescue Immunosuppressants in Liver Transplantation
J. M. Alamo et al.
TRANSPLANTATION PROCEEDINGS (2009)
Indications and Management of Everolimus After Liver Transplantation
I. Bilbao et al.
TRANSPLANTATION PROCEEDINGS (2009)
Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
Michael A. Zimmerman et al.
LIVER TRANSPLANTATION (2008)
Use of everolimus as a rescue immunosuppressive therapy in liver transplant patients with neoplasms
Judith Gomez-Camarero et al.
TRANSPLANTATION (2007)
Renal disease burden following liver transplantation
D. Y. Kim et al.
TRANSPLANTATION PROCEEDINGS (2006)
Chronic renal failure after transplantation of a nonrenal organ
AO Ojo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Recent advances in liver transplantation
RH Wiesner et al.
MAYO CLINIC PROCEEDINGS (2003)
End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy - Risk of development and treatment
TA Gonwa et al.
TRANSPLANTATION (2001)
Share Paper
